UBS Group
SSRI

UBS Group’s Silver Standard Resources SSRI Stock Holding History

UBS Group’s Portfolio SSRI Stock Details SSRI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,100
Closed -$26K – 8892
2015
Q4 		$26K Hold
5,100
– – ﹤0.01% 6501
2015
Q3 		$33K Sell
5,100
-6,000
-54% -$36.5K ﹤0.01% 6223
2015
Q2 		$70K Sell
11,100
-2,500
-18% -$14.8K ﹤0.01% 5708
2015
Q1 		$62K Buy
13,600
+4,200
+45% +$23.3K ﹤0.01% 5859
2014
Q4 		$47K Buy
+9,400
New +$49.4K ﹤0.01% 6578

Other funds holding SSRI

SCP
Syntal Capital Partners Midland, Texas $10M AUM 35.51% 1-Year Est. Return

UBS Group's SSRI Position: Q3 2017 in Review

UBS Group sold out of Silver Standard Resources (SSRI) in Q3 2017, closing a stake of 478,104 shares — an estimated $4.64M sold.

UBS Group first reported a position in SSRI in Q4 2014 and held it in 11 quarters. The position peaked at $4.64M in Q2 2017. 1 fund tracked by Wall St. Rank holds SSRI as of Q3 2017.

  • UBS Group reported no remaining Silver Standard Resources position as of Q3 2017 after selling out during the quarter.
  • UBS Group sold 478,104 Silver Standard Resources shares in Q3 2017, an estimated $4.64M.
  • UBS Group first reported a position in Silver Standard Resources in Q4 2014 and held it in 11 quarters.
  • UBS Group's Silver Standard Resources position peaked at $4.64M in Q2 2017.
  • 1 fund tracked by Wall St. Rank held Silver Standard Resources as of Q3 2017.

Based on UBS Group's 13F filing for Q3 2017, filed 14 Nov 2017.